CRYAB and tumors

doi:10.3760/cma.j.cn371439-20200311-00034

Abstract

Abstract:

AlphaB-crystallin (CRYAB) plays the role of molecular chaperone, it can maintain vascular endothelial growth factor levels and promote tumor neovascularization. Several recent studies indicate that CRYAB is abnormally expressed in various tumors such as breast cancer, lung cancer, colorectal cancer, and bladder cancer. It promotes tumor migration and invasion by promoting the resistance of tumor cells to apoptosis, regulating the secretion of matrix metalloproteinase and cadherin, and participating in the epithelial-mesenchymal transition process. The abnormal expression of CRYAB in tumor cells is significantly related to tumor stage, lymph node metastasis, overall survival and poor prognosis, and can be used as a new tumor marker.

Key words: Neoplasms, Neoplasm metastasis, Apoptosis, CRYAB

Dai Ang, Sun Qing. CRYAB and tumors[J]. Journal of International Oncology, 2020, 47(6): 351-354.

References 37

[1]	Haslbeck M, Vierling E. A first line of stress defense: small heat shock proteins and their function in protein homeostasis[J]. J Mol Biol, 2015,427(7):1537-1548. DOI: 10.1016/j.jmb.2015.02.002. doi: 10.1016/j.jmb.2015.02.002 pmid: 25681016
[2]	Qin H, Ni Y, Tong J, et al. Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer[J]. Med Oncol, 2014,31(8):142. DOI: 10.1007/s12032-014-0142-1. doi: 10.1007/s12032-014-0142-1 pmid: 25048725
[3]	Tao X, Cheng L, Li Y, et al. Expression of CRYAB with the angiogenesis and poor prognosis for human gastric cancer[J]. Medicine (Baltimore), 2019,98(45):e17799. DOI: 10.1097/MD.0000000000017799. doi: 10.1097/MD.0000000000017799
[4]	朱骏, 冯颖, 张峰, 等. 晶状体蛋白αb在结直肠癌组织中的表达及其临床意义[J]. 中国普外基础与临床杂志, 2015,22(11):1332-1337. DOI: 10.7507/1007-9424.20150348.
[5]	Shi QM, Luo J, Wu K, et al. High level of αB-crystallin contributes to the progression of osteosarcoma[J]. Oncotarget, 2016,7(8):9007-9016. DOI: 10.18632/oncotarget.6928. doi: 10.18632/oncotarget.6928 pmid: 26789112
[6]	Tan L, Sha L, Hou N, et al. High αB-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer[J]. Biosci Rep, 2019, 39(6). pii: BSR20182407. DOI: 10.1042/BSR20182407. doi: 10.1042/BSR20181147 pmid: 31160489
[7]	Huang Z, Cheng Y, Chiu PM, et al. Tumor suppressor alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties[J]. Oncogene, 2012,31(32):3709-3720. DOI: 10.1038/onc.2011.529. doi: 10.1038/onc.2011.529
[8]	Zhang C, Berndt-Paetz M, Neuhaus J. Identification of key biomar-kers in bladder cancer: evidence from a bioinformatics analysis[J]. Diagnostics (Basel), 2020,10(2) pii:E66. DOI: 10.3390/diagnostics10020066.
[9]	Tsang JY, Lai MW, Wong KH, et al. αB-crystallin is a useful marker for triple negative and basal breast cancers[J]. Histopathology, 2012,61(3):378-386. DOI: 10.1111/j.1365-2559.2012.04234.x. doi: 10.1111/j.1365-2559.2012.04234.x
[10]	Rajagopal P, Tse E, Borst AJ, et al. A conserved histidine modulates HSPB5 structure to trigger chaperone activity in response to stress-related acidosis[J]. Elife, 2015,4:e07304. DOI: 10.7554/eLife.07304. doi: 10.7554/eLife.07304
[11]	Bakthisaran R, Akula KK, Tangirala R. Phosphorylation of αB-crystallin: role in stress, aging and patho-physiological conditions[J]. Biochim Biophys Acta, 2016,1860(1 Pt B):167-182. DOI: 10.1016/j.bbagen.2015.09.017. doi: 10.1016/j.bbagen.2015.09.017 pmid: 26415747
[12]	Malin D, Petrovic V, Strekalova E, et al. αB-crystallin: portrait of a malignant chaperone as a cancer therapeutic target[J]. Pharmacol Ther, 2016,160:1-10. DOI: 10.1016/j.pharmthera.2016.01.012. doi: 10.1016/j.pharmthera.2016.01.012 pmid: 26820756
[13]	Yin B, Tang S, Xu J, et al. CRYAB protects cardiomyocytes against heat stress by preventing caspase-mediated apoptosis and reducing F-actin aggregation[J]. Cell Stress Chaperones, 2019,24(1):59-68. DOI: 10.1007/s12192-018-0941-y. doi: 10.1007/s12192-018-0941-y pmid: 30246229
[14]	Malin D, Strekalova E, Petrovic V, et al. ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo[J]. Oncogene, 2015,34(45):5626-5634. DOI: 10.1038/onc.2015.12. doi: 10.1038/onc.2015.12 pmid: 25684139
[15]	van de Schootbrugge C, van Asten F, Nagtegaal ID, et al. αB-crystallin expression is correlated with phospho-ERK1/2 expression in human breast cancer[J]. Int J Biol Markers, 2013,28(4):e365-e370. DOI: 10.5301/JBM.5000032. doi: 10.5301/jbm.5000032 pmid: 23722303
[16]	Malin D, Strekalova E, Petrovic V, et al. αB-crystallin: a novel regulator of breast cancer metastasis to the brain[J]. Clin Cancer Res, 2014,20(1):56-67. DOI: 10.1158/1078-0432.CCR-13-1255. doi: 10.1158/1078-0432.CCR-13-1255 pmid: 24132917
[17]	Chen Z, Ruan Q, Han S, et al. Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo[J]. Breast Cancer Res Treat, 2014,145(1):45-59. DOI: 10.1007/s10549-014-2940-8. doi: 10.1007/s10549-014-2940-8 pmid: 24710637
[18]	邓亚平, 钟晶敏, 李晶, 等. 乳腺癌中α-晶状体B链蛋白表达的临床病理研究[J]. 现代生物医学进展, 2016,16(29):5663-5666. DOI: 10.13241/j.cnki.pmb.2016.29.016.
[19]	Sultan G, Zubair S, Tayubi IA, et al. Towards the early detection of ductal carcinoma (a common type of breast cancer) using biomarkers linked to the PPAR(γ) signaling pathway[J]. Bioinformation, 2019,15(11):799-805. DOI: 10.6026/97320630015799. doi: 10.6026/97320630015799 pmid: 31902979
[20]	Guo Z, Song J, Hao J, et al. M2 macrophages promote NSCLC metastasis by upregulating CRYAB[J]. Cell Death Dis, 2019,10(6):377. DOI: 10.1038/s41419-019-1618-x. doi: 10.1038/s41419-019-1618-x pmid: 31097690
[21]	Chen D, Cao G, Qiao C, et al. Alpha B-crystallin promotes the invasion and metastasis of gastric cancer via NF-κB-induced epithelial-mesenchymal transition[J]. J Cell Mol Med, 2018,22(6):3215-3222. DOI: 10.1111/jcmm.13602. doi: 10.1111/jcmm.13602 pmid: 29566309
[22]	Shi C, Yang X, Bu X, et al. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition[J]. Biochem Biophys Res Commun, 2017,489(4):369-374. DOI: 10.1016/j.bbrc.2017.05.070. doi: 10.1016/j.bbrc.2017.05.070 pmid: 28506831
[23]	Li Q, Wang Y, Lai Y, et al. HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling[J]. PLoS One, 2017,12(8):e0182588. DOI: 10.1371/journal.pone.0182588. doi: 10.1371/journal.pone.0182588 pmid: 28796798
[24]	Zhang L, Zhang L, Xia X, et al. Krüppel-like factor 4 promotes human osteosarcoma growth and metastasis via regulating CRYAB expression[J]. Oncotarget, 2016,7(21):30990-31000. DOI: 10.18632/oncotarget.8824. doi: 10.18632/oncotarget.8824 pmid: 27105535
[25]	Wang SN, Luo S, Liu C, et al. miR-491 inhibits osteosarcoma lung metastasis and chemoresistance by targeting αB-crystallin[J]. Mol Ther, 2017,25(9):2140-2149. DOI: 10.1016/j.ymthe.2017.05.018. doi: 10.1016/j.ymthe.2017.05.018 pmid: 28648665
[26]	Yilmaz M, Karatas OF, Yuceturk B, et al. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues[J]. Head Neck, 2015,37(9):1344-1348. DOI: 10.1002/hed.23746. doi: 10.1002/hed.23746 pmid: 24817638
[27]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019,69(1):7-34. DOI: 10.3322/caac.21551. doi: 10.3322/caac.21551 pmid: 30620402
[28]	张文君, 刘斌, 令狐华. 晶状体蛋白αB对卵巢癌细胞恶性行为的影响[J]. 第三军医大学学报, 2017,39(3):223-228. DOI: 10.16016/j.1000-5404.201609030.
[29]	李华, 刘兴元, 王玲, 等. 发病年龄对子宫内膜癌患者预后的影响分析[J]. 癌症进展, 2016,14(07):696-698. DOI: 10.11877/j.issn.1672-1535.2016.14.07.27.
[30]	Wyciszkiewicz A, Kalinowska-Łyszczarz A, Nowakowski B, et al. Expression of small heat shock proteins in exosomes from patients with gynecologic cancers[J]. Sci Rep, 2019,9(1):9817. DOI: 10.1038/s41598-019-46221-9. doi: 10.1038/s41598-019-46221-9 pmid: 31285463
[31]	高瑾, 李丽, 赵娟, 等. 慢病毒介导的αB-晶状体蛋白基因沉默对子宫内膜癌ISK细胞增殖和迁移能力的影响[J]. 现代肿瘤医学, 2017,25(18):2865-2869. DOI: 10.3969/j.issn.1672-4992.2017.18.002.
[32]	Kori M, Yalcin Arga K. Potential biomarkers and therapeutic targets in cervical cancer: insights from the meta-analysis of transcriptomics data within network biomedicine perspective[J]. PLoS One, 2018,13(7):e0200717. DOI: 10.1371/journal.pone.0200717. doi: 10.1371/journal.pone.0200717 pmid: 30020984
[33]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492. doi: 10.3322/caac.21492 pmid: 30207593
[34]	Ho PY, Chueh SC, Chiou SH, et al. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance[J]. Urol Oncol, 2013,31(7):1367-1377. DOI: 10.1016/j.urolonc.2012.01.015. doi: 10.1016/j.urolonc.2012.01.015 pmid: 22417627
[35]	Wang Z, Wang L, Huang ZX, et al. Contrast functions of αA- and αB-crystallins in cancer development[J]. Curr Mol Med, 2017,16(10):914-922. DOI: 10.2174/1566524016666161223110508. doi: 10.2174/1566524016666161223110508 pmid: 28017134
[36]	Ruan H, Li Y, Wang X, et al. CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways[J]. Jpn J Clin Oncol, 2020,50(3):254-260. DOI: 10.1093/jjco/hyz172. doi: 10.1093/jjco/hyz172 pmid: 31829429
[37]	Valcarcel-Jimenez L, Macchia A, Martín-Martín N, et al. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer[J]. Cell Death Dis, 2018,9(10):1041. DOI: 10.1038/s41419-018-1096-6. doi: 10.1038/s41419-018-1096-6 pmid: 30310055

CRYAB and tumors

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 37

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.